3879 results for «360»
3879 results
TAVI: complex vascular access - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session focuses on managing complex vascular access challenges in TAVI procedures. It includes case discussions on non-crossable aortic valve stenosis, transseptal TAVI for severe aortic regurgitation with porcelain aorta, and percutaneous implantation in patients with unconventional anatomy or conditions like shaggy syndrome. Strategies for severe...
TAVI valve-in-valve - Part 6
18 Nov 2025 – From PCR London Valves 2025
This session explores valve-in-valve TAVI procedures, addressing intricate cases such as triple valve scenarios, planning challenges in TAVI-in-TAVI, and overcoming obstacles in mitral valve-in-valve therapies. It also presents difficult cases involving dysfunctional stentless aortic bioprostheses and acute leaflet rupture during valve replacement, offering practical insights for...
TAVI: alternative access - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session addresses alternative access routes for TAVI in patients with challenging vascular anatomy. Topics include transapical valve-in-valve procedures complicated by severe aortic regurgitation, percutaneous TAVI via the brachiocephalic trunk, and strategies for managing hostile vascular anatomies. Solutions for scenarios where transfemoral TAVI is not feasible...
Challenging mitral interventions
18 Nov 2025 – From PCR London Valves 2025
This session explores the complexities of mitral interventions, highlighting advancements and challenges in transcatheter mitral valve repair (TMVR). Topics include the benefits of a simplified single-step TMVR approach, the influence of hemodynamic parameters on MitraClip therapy outcomes, strategies for managing persistent pulmonary oedema, and approaches to...
TAVI and coronary artery disease - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session focuses on the intersection of transcatheter aortic valve implantation (TAVI) and coronary artery disease, addressing complex clinical scenarios. It covers innovative approaches such as double "chimney" stenting with balloon-expandable TAVI, strategies for high-risk TAVR combined with multivessel PCI, advances in Medtronic Fx+ TAVR technology,...
When the interventional cardiologist meets the surgeon
18 Nov 2025 – From PCR London Valves 2025
This session highlights collaborative approaches between interventional cardiologists and surgeons in complex valve interventions. It includes cases such as transfemoral valve-in-valve TAVI in bio-Bentall patients with chronic aortic dissection, critical decision-making in life-threatening scenarios, the importance of access choice in TMVR, mechanical leaflet modification of failed...
TAVI: LIVE Educational Case from St. Thomas' Hospital - London, UK
18 Nov 2025 – From PCR London Valves 2025
This educational session presents a live TAVI case from St. Thomas' Hospital in London, providing detailed insights into patient presentation, imaging analysis, operator strategy, and device selection. It includes a live procedural demonstration complemented by a recorded case from Erasmus University Medical Center in Rotterdam, offering...
Paravalvular leak closure - Part 4
18 Nov 2025 – From PCR London Valves 2025
This session delves into the complexities of paravalvular leak closure with a focus on challenging scenarios including unusual TAVI complications in the mitral position, management of mega paravalvular leaks using jumbo devices, and strategies when closure itself poses an obstacle. It also covers acute peri-operative aortic...
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
Cardiovalve hits the TARGET: advancing transcatheter valve replacement
18 Nov 2025 – From PCR London Valves 2025
This session highlights the features and procedural steps of the next-generation Cardiovalve systems for tricuspid and mitral valve replacement. It reviews interim results from the TARGET study, emphasizing echocardiographic findings and reverse remodeling effects, and discusses best practices for patient selection and the learning pathway to...
Cracking the tricuspid code "the Bicaval revolution"
16 Nov 2025 – From PCR London Valves 2025
This session decodes the advancement of caval valve therapy with the TricValve system, offering novel solutions for tricuspid regurgitation and right heart failure. It incorporates insights from clinical trials, real-world cases, and guideline integration, detailing imaging techniques and strategies for complex patient management including rescue interventions.
Day case TAVI - The future standard of care for most TAVI patients
16 Nov 2025 – From PCR London Valves 2025
Examining the UK experience, this session discusses the emerging standard of day case TAVI and its potential application across Europe. It evaluates patient-centered risks and benefits, operational requirements, and the evolving role of clinical valve coordinators to facilitate safe and efficient day case pathways for TAVI...
Transcatheter tricuspid valve replacement
16 Nov 2025 – From PCR London Valves 2025
This session reviews contemporary advances in transcatheter tricuspid valve replacement (TTVR). It highlights long-term follow-up data from tricuspid valve-in-valve cases, introduces the novel Vdyne valve device for tricuspid regurgitation, and discusses timing considerations for interventions following surgical aortic valve replacement. Additionally, it evaluates the role of...
Exceptional engineering, predictable outcomes - Latest development of the VitaFlow TAVI device
17 Nov 2025 – From PCR London Valves 2025
Discover the latest advancements in the VitaFlow transcatheter aortic valve implantation (TAVI) device. This session highlights the electronically enabled VitaFlow Liberty system, delivering consistent immediate and mid-term clinical results. Watch real-world demonstrations of complex cases, including heavily calcified aortas and pure aortic regurgitation, and get a...
Curious mitral and tricuspid scenarios
16 Nov 2025 – From PCR London Valves 2025
This session presents a series of challenging and unusual clinical scenarios involving mitral and tricuspid valve disease. Topics include management of acute primary mitral regurgitation in high-surgical-risk patients, technical challenges in transcatheter mitral valve replacement (TMVR), and complex cases where cardiac rhythm disturbances interplay with valvular...
From innovation to intervention: optimising procedural techniques in tricuspid TEER
17 Nov 2025 – From PCR London Valves 2025
Explore advanced strategies for tricuspid TEER in this PCR London Valves 2025 session.
Through real-world cases and interactive simulation, learn how to optimise outcomes in complex tricuspid anatomy, manage challenges posed by pacemaker leads, and enhance procedural efficiency using the TriClip G5 device.
Gain practical insights on clipping...
From repair to replacement: a portfolio of options for your mitral and tricuspid regurgitation patients
16 Nov 2025 – From PCR London Valves 2025
This session explores a full spectrum of therapeutic options for mitral and tricuspid regurgitation, focusing on the PASCAL Precision system for targeted repair and the SAPIEN M3 transcatheter mitral valve replacement. Through beating heart simulators, case discussions, and clinical evidence, participants will understand the versatility and...
Getting the full potential of the supra-annular valve in a changing landscape
16 Nov 2025 – From PCR London Valves 2025
This session explores the evolving landscape of transcatheter aortic valve implantation (TAVI) with a focus on supra-annular valve technology. It covers techniques for achieving commissural alignment, considerations for small aortic annuli, and advantages in treating bicuspid aortic valve disease, supported by clinical data and illustrative cases.
The Top Late-Breaking Trials - Part 1
16 Nov 2025 – From PCR London Valves 2025
This session presents pivotal late-breaking trials in transcatheter mitral and aortic valve interventions. Explore one-year outcomes from the AltaValve early feasibility study featuring atrial fixation TMVR, interim results from the TARGET study assessing Cardiovalve for tricuspid regurgitation, five-year data on transapical TMVR, and outcomes of TAVI...
Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV
17 Nov 2025 – From PCR London Valves 2025
This session addresses emerging topics in structural heart disease by examining patient-centered solutions such as EVOQUE transcatheter tricuspid valve replacement (TTVR) and SAPIEN transcatheter heart valve-in-heart valve (THV-in-THV) procedures. It covers the latest data from Europe on redo TAVI, lifetime management strategies beginning with initial prosthesis...
